|Articles|February 28, 2020
Synteract Launches Rare Disease Institute
Advertisement
Synteract has launched the Synteract Rare Disease Institute. The program incorporates lectures, webinars, interactive discussions, videos, and industry literature that cover a wide variety of topics from patient perspectives, bioethics to customer engagement and more.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Unlocking Unstructured Health Data: Scaling eSource-Enabled Clinical Trials
2
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
5